Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBbva Ord Regulatory News (BVA)

Share Price Information for Bbva Ord (BVA)

Share Price is delayed by 15 minutes
Get Live Data
20.90    -0.10 (-0.48%)
Bid:
20.90
Ask:
21.90
Spread: 1.00 (4.785%)
Market Cap: €115.95b
BVA Live PriceLast checked at - London Stock Exchange

Intraday Bbva Ord Share Chart

Stabilisation Notice - BBVA

11 Mar 2025 09:27

RNS Number : 1910A
Societe Generale SA
11 March 2025
 

11th March 2025

 

Not for distribution, directly or indirectly, in or into the United States or any jurisdiction in which such distribution would be unlawful.

Banco Bilbao Vizcaya Argentaria S.A.("BBVASM")

Post-stabilisation Period Announcement

Societe Generale (contact: Damien Dupont +44 20 7676 7531) hereby gives notice that no stabilisation (within the meaning of Article 3.2(d) of the Market Abuse Regulation (EU/596/2014) [as it forms part of domestic law by virtue of the European Union (Withdrawal) Act 2018]) was undertaken by the Stabilisation Manager(s) named below in relation to the offer of the following securities.

Securities

Issuer:

Banco Bilbao Vizcaya Argentaria S.A.("BBVASM")

Guarantor(s) (if any):

N/A

Aggregate nominal amount:

EUR 1bn

Description:

Coupon: 4.000% Fixed rate

Maturity: 25 February 2037(12-year)

Offer price:

99.91

 

 

Stabilisation:

Stabilisation Manager(s)

SG CIB

Stabilisation period expected to start on

17/02/2025

Stabilisation period expected to end no later than

27/03/2025

Existence, maximum size and conditions of use of overallotment facility:

The Stabilisation Manager(s) may overallot the securities to the extent permitted in accordance with applicable law.

This announcement is for information purposes only and does not constitute an invitation or offer to underwrite, subscribe for or otherwise acquire or dispose of any securities of the Issuer in any jurisdiction.

This announcement is not an offer of securities for sale into the United States. The securities referred to above have not been, and will not be, registered under the United States Securities Act of 1933 and may not be offered or sold in the United States absent registration or an exemption from registration. There has not been and will not be a public offer of the securities in the United States.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
STAGCGDXLDBDGUB
Date   Source Headline
1st Feb 20187:04 amRNS4Q17 Results Report
1st Feb 20187:02 amRNS4Q17 Results Press Release
1st Feb 20187:00 amRNSProposal for payment of dividend
25th Jan 20185:25 pmRNS4Q17 Results Presentation Announcement
10th Jan 20187:00 amRNSAssessment of the shareholding at Telefonica, S.A
28th Dec 20173:26 pmRNSGMTN Programme Supplement to the Offering Circular
27th Dec 201712:59 pmRNSGMTN Programme - Issuer Substitution
27th Dec 201712:42 pmRNSGMTN Programme
21st Dec 20176:29 pmRNSPost Stabilisation Notice
15th Dec 20174:00 pmRNSPublication of approved ECP Information Memorandum
13th Dec 20175:35 pmRNSSREP Capital Requirements 2018
5th Dec 20177:22 amRNSTransmissions and purchases of capital undertaking
4th Dec 201710:47 amRNSFinal Terms 154SNP
29th Nov 20178:13 amRNSSale of real estate business
28th Nov 20177:00 amRNSBinding offer for the acquisition of BBVA Chile
24th Nov 20171:25 pmRNSFinal Terms 153SNP
10th Nov 201712:31 pmRNSFinal Terms Global Medium Term Note Programme
9th Nov 20177:00 amRNSAT1 Issuance for a total nominal amount
8th Nov 201710:52 amRNSPre Stabilisation Notice
7th Nov 20171:10 pmRNSOffer of securities contingently convertible
27th Oct 20174:29 pmRNSGMTN programme Supplement to the Offering Circular
27th Oct 20177:00 amRNSBBVA communicates its 3Q17 results presentation
27th Oct 20177:00 amRNSBBVA communicates its 3Q17 results report
27th Oct 20177:00 amRNSBBVA communicates its 3Q17 results press release
23rd Oct 20175:33 pmRNS3Q17 Results Presentation Announcement
6th Oct 201711:39 amRNSPost Stabilisation Notice BBVA EUR 5yr SNP
28th Sep 20177:55 amRNSHR News Real Estate
28th Sep 20177:00 amRNSDividend October 2017
4th Sep 20174:33 pmRNSFinal Terms 152 Execution version
31st Aug 20177:47 amRNSBBVA Chile News
30th Aug 20178:30 amRNSPre Stabilisation Notice BBVA 5yr EUR SNP
2nd Aug 20177:57 amRNSDBRS upgrades BBVA´s Cédulas Hipotecarias rating
1st Aug 201712:53 pmRNSFinal Supplement 2Q17
27th Jul 20176:04 pmRNS2Q17 Results Report
27th Jul 20175:46 pmRNS2Q17 Results Presentation
27th Jul 20175:30 pmRNS2Q17 Results Press Release
25th Jul 20175:39 pmRNSScope upgrades BBVA's senior unsecured rating
20th Jul 20175:18 pmRNSResults Presentation Announcement
12th Jun 20177:00 amRNSDBRS changes subordinated debt ratings
1st Jun 20177:00 amRNSBoard of Directors changes
25th May 201712:32 pmRNSFinal Terms GMTN151SUB
25th May 201711:26 amRNSFinal Terms
17th May 20177:00 amRNSAT1 Issuance
5th May 201712:55 pmRNSDividend Option
3rd May 201711:58 amRNSsupplemental to the Offering Circular
28th Apr 20178:43 amRNS2016 Audited Financial Statements
27th Apr 20177:00 amRNS1Q17 Results Report
27th Apr 20177:00 amRNS1Q17 Results Presentation
27th Apr 20177:00 amRNS1Q17 Press Release
24th Apr 20177:00 amRNSEnding trading period Dividend Option April 2017

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.